Ardena’s expanded nanomedicine facility granted full GMP approval
The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles Ardena has announced the full...
Selected News
New PAGB research highlights importance of self-care for easy-to-treat conditions
The census found that 56% of people visit their GP for a UTI and 27% for thrush New research from...
Teva and Immunai partner to improve clinical decision making
The companies will focus on mechanisms of action, dose selection and biomarker analyses Teva Pharmaceuticals and artificial intelligence (AI)-driven Immunai...
Microbiotica begins human trials for ulcerative colitis treatment
First patient dosed in phase 1b trial of MB310 therapy Microbiotica, a clinical-stage biopharma company, has announced the dosing of...
Vivolta and Neurochase to produce brain therapy catheters
New long-term partnership to address neurological disorder treatments Vivolta, a specialist in medical electrospinning solutions, has entered a long-term partnership...
Lupin to develop near-zero global warming inhalers
Eco-friendly inhalers aim to reduce environmental impact Lupin Healthcare UK Ltd has announced plans to reformulate its pMDI inhalers with...
Infinitopes to showcase cancer vaccine breakthroughs at SITC
Insight into double-blind, phase i/ii clinical trial for oesophageal cancer Infinitopes, an integrated cancer biotech firm, will present its pioneering...
Arcellx to present positive data on multiple myeloma treatments
Phase 1 and 2 studies show promising results for anito-cel therapy Arcellx Inc, a biotechnology firm focused on cell therapy...
MHRA grants approval for bladder cancer drug erdafitinib
New therapy targets specific genetic alterations, promises extended survival Johnson & Johnson has announced that the UK’s Medicines and Healthcare...
NICE recommends remote monitoring technology for heart failure patients
Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020 The National Institute for Health and...
UK dementia clinical trial participation set to boost by ‘tens of thousands’
The new Dementia Trials Accelerator is set to receive £20m of government funding The Dementia Trials Accelerator, led by the...
WHO report highlights resurgence of tuberculosis
Approximately 8.2 million people were diagnosed with the infectious disease in 2023 The World Health Organization’s (WHO) newly published report...
NICE recommendation for new Alexion PNH treatment
danicopan shown to improve haemoglobin levels and reduce anaemia Alexion, AstraZeneca Rare Disease, announced that the National Institute for Health...
Darzalex subcutaneous regimen approved by European Commission
New treatment option for patients with newly diagnosed multiple myeloma The European Commission has approved the subcutaneous (SC) formulation of...
Calluna Pharma completes successful phase 1 trial of new fibrotic disease drug
CAL101 shows promising results and is set to enter phase 2 development Calluna Pharma AS has announced the successful completion...
Valneva Scotland announces year-long support for local cancer charity Team Jak
The company’s workforce will volunteer and fundraise for Team Jak throughout the year Valneva Scotland has partnered with Team Jak,...
NICE recommends Santen’s Roclanda to treat glaucoma and ocular hypertension
Primary open-angle glaucoma affects around 2% of adults aged 40 years and older in the UK The National Institute for...
Learna and University of Wolverhampton launch flexible healthcare courses
The five new programmes are designed to fit alongside full-time work and clinical practice Learna and the University of Wolverhampton...
New £4.5m initiative launched to address UK medicines manufacturing skills shortage
The two-year programme will use virtual reality technology to teach essential skills A £4.5m initiative has been launched to address...
Vivan renews five-year lease at UK biotech hub White City Place
The London hub is home to life sciences companies including Novartis, Engitix and invoX Pharma Vivan Therapeutics has signed a...
